In Vivo Fluorescence Imaging to target HER2 Receptor

Moinuddin Hassan; Sang Bong Lee; Jason Riley; Victor Chernomordik; Jacek Capala; Amir H. Gandjbakhche

doi:10.1364/BIOMED.2008.BTuD8

Biomedical Optics
OSA Technical Digest (CD) (Optica Publishing Group, 2008),
paper BTuD8
•https://doi.org/10.1364/BIOMED.2008.BTuD8

In Vivo Fluorescence Imaging to target HER2 Receptor

Moinuddin Hassan, Sang Bong Lee, Jason Riley, Victor Chernomordik, Jacek Capala, and Amir H. Gandjbakhche

Biomedical Optics 2008

St. Petersburg, Florida United States
16–19 March 2008
ISBN:

From the session
Optical Cancer Diagnostics (BTuD)

Not Accessible

Your library or personal account may give you access

Get PDF
Email
Share
Get Citation
Copy Citation Text
M. Hassan, S. B. Lee, J. Riley, V. Chernomordik, J. Capala, and A. H. Gandjbakhche, "In Vivo Fluorescence Imaging to target HER2 Receptor," in Biomedical Optics, OSA Technical Digest (CD) (Optica Publishing Group, 2008), paper BTuD8.

Export Citation
- BibTex
- Endnote (RIS)
- HTML
- Plain Text
Citation alert
Save article

Abstract

The goal of our study is to develop a non-invasive optical method for monitoring of HER2 receptor in-vivo and HER2-specific delivery of therapeutic agents to individualize treatment of HER2-positive cancers (breast cancer).

PDF Article

Previous Article Next Article